Deal overview
| Target | PRINCIPIA BIOPHARMA INC |
|---|---|
| Bidder | SANOFI SA |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | Aug 17, 2020 |
| Abstract | On 17 August 2020, the quoted French pharmaceutical company Sanofi SA ("Sanofi") announced a recommended cash offer for Principia Biopharma Inc ("Principia"), a Nasdaq listed biopharmaceutical company. The offer of $100 per share represented an aggregate equity value of approximately $3.68 billion (on a fully diluted basis). The offer was expected to commence later that ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
Search for Deals
Search over 70 million deal reports on more than 550,000 public and private companies. (copy)
©2020 M&A Monitor Limited
